A preliminary study on the effect of a lactic acid bacteria intake on immune function. -a open-label, single-arm trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000046586
- Lead Sponsor
- IMEQRD Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1.Individuals who have mouth dryness, or Sjogren's syndrome. 2.Individuals who are currently undergoing treatment for any disease. 3.Individuals who have been receiving nutritional and exercise therapy under medical doctor's management. 4.Individuals who have severe diseases or a history of severe diseases. 5.Individuals who have allergic dermatitis, allergic rhinitis, bronchial asthma, or chronic bronchitis. 6.Individuals who have currently been taking commercially available drugs, quasi-drug products, and foods, drinks, or supplements with any functional claims. 7.Individuals who have been taking yogurts, beverages, health foods, supplements which include lactic acid bacteria and/or Bifidobacterium. 8.Individuals who have a drug allergy, or a food allergy. 9.Individuals who are currently pregnant or breastfeeding, or planning to pregnant during the study period. 10.Individuals who work in shift and night shift. 11.Individuals who are planning travel to foreign countries during the study period. 12.Individuals who drink more than 60 g alcohol/day. 13.Individuals who have been vaccinated to protect against infectious diseases, such as influenza virus or SARS-CoV-2, one month before the screening period. Also, individuals who are planning vaccination during the study period. 14.Individuals who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the study period. 15.Individuals who joined other clinical trials from one month before obtaining informed consent in this study, or individuals who have currently been joined other clinical trials. Also, individuals who are planning to join other clinical trials. 16.Individuals who are unsuitable for this study, that judged by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immune function-related markers Questionnaire for physical health Questionnaire for fatigue assessment
- Secondary Outcome Measures
Name Time Method